ALP Bio
Developer of immune organoid and AI platform to identify, understand, and reduce immunogenicity risk earlier in antibody development
Country
Email Address
info@alp.bio
Founded Date
2025
Headquarters
Investors
Latest Funding Round Date
April 30, 2026
Latest Funding Round Amount (USD)
2,200,000
Latest Funding Type
LinkedIn URL
Location
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
2,200,000
Official Website
Find more companies like ALP Bio
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.